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Abstract
Deep brain stimulation of the subthalamic nucleus (STN DBS) provides a unique window into
human brain function since it can reversibly alter the functioning of specific brain circuits. Basal
ganglia–cortical circuits are thought to be excessively noisy in patients with Parkinson’s disease
(PD), based in part on the lack of specificity of proprioceptive signals in basal ganglia–thalamic–
cortical circuits in monkey models of the disease. PD patients are known to have deficits in
proprioception, but the effects are often subtle, with paradigms typically restricted to one or two
joint movements in a plane. Moreover, the effects of STN DBS on proprioception are virtually
unexplored. We tested the following hypotheses: first, that PD patients will show substantial
deficits in unconstrained, multi-joint proprioception, and, second, that STN DBS will improve
multi-joint proprioception. Twelve PD patients with bilaterally implanted electrodes in the
subthalamic nucleus and 12 age-matched healthy subjects were asked to position the left hand at a
location that was proprioceptively defined in 3D space with the right hand. In a second condition,
subjects were provided visual feedback during the task so that they were not forced to rely on
proprioception. Overall, with STN DBS switched off, PD patients showed significantly larger
proprioceptive localization errors, and greater variability in endpoint localizations than the control
subjects. Visual feedback partially normalized PD performance, and demonstrated that the errors
in proprioceptive localization were not simply due to a difficulty in executing the movements or in
remembering target locations. Switching STN DBS on significantly reduced localization errors
from those of control subjects when patients moved without visual feedback relative to when they
moved with visual feedback (when proprioception was not required). However, this reduction in
localization errors without vision came at the cost of increased localization variability.
Keywords
human; proprioception; deep brain stimulation; subthalamic nucleus; Parkinson’s disease
© 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
*Correspondence to: Institute for Neural Computation, University of California, San Diego, 9500 Gilman Drive – 0523, La Jolla, CA
92093-0523, United States. Tel: +1-858-822-6765; fax: +1-858-534-2014. hpoizner@ucsd.edu.†Present address: Department of Electrical Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of
Korea. Center for Integrated Smart Sensors, Daejoen, Republic of Korea.
NIH Public Access
Author Manuscript
Neuroscience. Author manuscript; available in PMC 2014 August 06.
Published in final edited form as:
Neuroscience. 2013 August 6; 244: 99–112. doi:10.1016/j.neuroscience.2013.04.009.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
INTRODUCTION
It has recently become clear that Parkinson’s disease (PD) involves impairments in sensory
as well as in motor functions (Chaudhuri and Schapira, 2009; Juri et al., 2010). In particular,
a growing body of literature demonstrates that PD patients show deficits in proprioception
(Konczak et al., 2009), a sensory modality critically important for the control of movement
(Sainburg et al., 1995; Sober and Sabes, 2003). Loss of proprioception leads to a marked
dependence on external stimuli to guide movement (Ghez and Sainburg, 1995; Sainburg et
al., 1995, 2003), a known characteristic of PD patients (Flowers, 1976; Flowers and
Downing, 1978; Flash et al., 1992; Klockgether and Dichgans, 1994; Adamovich et al.,
2001). Blocking PD patients from visually tracking their moving hand can be especially
disabling, even more than requiring spatial memory to localize a spatial target (Flash et al.,
1992; Klockgether and Dichgans, 1994; Adamovich et al., 2001). Indeed, PD patients show
impaired proprioception when discriminating bilateral elbow joint angles (Zia et al., 2000)
or in detecting changes in either proximal or distal limb position (Maschke et al., 2003;
Putzki et al., 2006). They show a reduced vibration-induced movement (Rickards and Cody,
1997; Schrader et al., 2008), elevated thresholds in judging the curvature of their arm paths
when their arm is passively moved (Konczak et al., 2008), and impaired dynamic estimation
of hand position during multi-joint reaching movements (Contreras-Vidal and Gold, 2004).
Axial proprioception is impaired as well as limb proprioception (Wright et al., 2010).
Furthermore, PD patients show deficits in the temporal as well as spatial discrimination of
proprioceptive inputs (Fiorio et al., 2007). Electroencephalographic studies reveal altered
late, but not early, cortical potentials to passive limb movement in PD, reflecting impaired
cortical processing of proprioception (Seiss et al., 2003). Importantly, these deficits in
proprioception are thought to contribute to the motor impairments in PD (Keijsers et al.,
2005; Konczak et al., 2009; Wright et al., 2010).
Several studies have examined whether dopaminergic therapy reverses proprioceptive
deficits in PD, but the results are conflicting. O’Suilleabhain (2001) found that
dopaminergic therapy acutely worsened limb proprioception. Mongeon et al. (2009)
likewise found that it worsened limb proprioception, but only in some patients. In contrast,
Maschke et al. (2003) found that dopaminergic therapy had no effect on limb
proprioception, while Li et al. (2010) found that it improved limb proprioception.
Even less is known about the effects of deep brain stimulation of the subthalamic nucleus
(STN DBS) on proprioception. In this surgical therapy that is gaining wide acceptance,
stimulating electrodes are implanted bilaterally in the STN. As with dopaminergic therapy,
STN DBS markedly improves PD motor function (Deep Brain Stimulation for Parkinson’s
Disease Study Group, 2001). Yet, only one study that we are aware of has directly examined
the effects of STN DBS on proprioception. Maschke et al. (2005) found that STN DBS
produced a small but significant improvement in proprioceptive acuity in a task in which
patients’ had to detect passive forearm displacements.
Although PD patients have consistently shown proprioceptive deficits in a variety of
experimental studies, the deficits have been subtle. Therefore, in order to examine the
effects of STN DBS on proprioception, we wanted to use a task that challenged
proprioceptive processing. The one previous study examining the effects of STN DBS on
proprioception used a single joint elbow displacement task (Maschke et al., 2005). Control
subjects were extremely accurate in that task, having a detection threshold of 0.9 degree arm
displacement. PD patients off DBS had an elevated threshold, but its magnitude was only
2.5 degrees. This created something of a ceiling effect against which to show any possible
effect of DBS. In the present study, we selected a psychophysical paradigm previously used
to test proprioception and known to elicit large errors in healthy subjects (Tillery et al.,
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1994). Thus, we hoped to avoid baseline ceiling (or floor) effects in the evaluation of STN
DBS modulation of proprioception.
Since the STN receives direct afferents from primary and secondary somatosensory cortices
(Canteras et al., 1988; Juri et al., 2010) as well as from sensory processing areas of the
thalamus (Lanciego et al., 2004) STN DBS could stimulate these somatosensory-related
areas antidromically and interfere with abnormal firing patterns and pathological oscillations
(Gradinaru et al., 2009), as well as orthodromically override faulty oscillatory and firing
pattern activity in target structures (Xu et al., 2008). Moreover, STN DBS is thought to
reduce pathological noise in basal ganglia–cortical circuits (Montgomery and Gale, 2008)
and thus may improve behavioral variability (Guehl et al., 2006).
The hypotheses of the study were twofold. First, we hypothesized that PD patients would
show substantial proprioceptive deficits in a challenging proprioceptive processing task. We
tested this hypothesis by comparing the accuracy and precision (variability) of multi-joint
localization of the limb in 3D space in PD patients off stimulation with those of control
subjects. If PD patients show proprioception-specific deficits, they should show a relatively
greater benefit from receiving visual feedback of the limbs than would control subjects.
Second, since STN DBS is thought to reduce pathological noise in basal ganglia-cortical
circuits, and since there is initial evidence that STN DBS improves single joint
proprioception (Maschke et al., 2005), we hypothesized that STN DBS would produce
improvements in the accuracy and precision of limb localization. If so, then switching on
STN DBS should produce relatively greater improvements in limb localization when visual
feedback of the limb is not provided, than when visual guidance of movement is possible.
A preliminary analysis of this experiment was presented in abstract form (Lee et al., 2009).
EXPERIMENTAL PROCEDURES
Subjects
Twelve patients with PD (mean age ± SD = 68 ± 7.5, 11 males) who had bilaterally
implanted stimulating electrodes in the STN, and 12 controls (70 ± 6.3, five males)
participated and ages of two groups did not significantly differ (t(22) = 0.72, p = 0.48). All
PD patients had moderate PD (stages II to III of the Hoehn and Yahr scale (Hoehn and Yahr,
1967)), were clinically typical, and their motor disabilities were responsive to anti-
parkinsonian medications. STN DBS produced a significant improvement in motor
symptoms (mean Unified Parkinson’s Disease Rating Scale, UPDRS (Goetz and Stebbins,
1995), score of 35.7 for ON and 48.2 for OFF stimulation (t(11) = 9.68, p < 0.001)). Patients
were screened for major cognitive impairment (Mini Mental State Examination (Folstein et
al., 1975)) and depression (Beck Depression Inventory, Psychological Corporation, Boston,
MA, USA). Table 1 presents the clinical characteristics of the patients. All patients but one
were tested on their regular anti-parkinsonian medications (this subject was not on any anti-
parkinsonian medication following surgery). Doses of such medications were markedly
reduced from the levels used prior to STN DBS surgery. All subjects were free from
significant upper limb or trunk arthritis or pain, and were without any significant
neurological or psychiatric disease, except for Parkinson’s disease in the PD patients.
Subjects were tested for hand dominance based on the Edinburgh Handedness Inventory
(Oldfield, 1971). All PD and control subjects were right-handed except for one female
control who was left-handed. After detailed explanation of the procedures, all subjects
signed a consent form approved by the institutional review board of the University of
California at San Diego.
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Apparatus and experimental setup
Subjects sat in front of a five degree-of-freedom robot arm (Thermo Fischer Scientific Inc.,
Catalyst 5, Waltham, MA, USA). The robot pseudorandomly presented one of five targets
drawn from a pyramidal array centered on the subject’s midline (Fig. 1A). Four targets (up,
down, left, and right) formed a diamond in a frontal plane. The length of the two diagonals
was 40 cm. Target ‘back’ was located along the subject’s midline but 15 cm farther posterior
than the first plane, at a distance approximately equal to the length of the subject’s arm with
clenched fist with the arm extended. Thus, subjects were able to reach to the targets
comfortably without fully extending their arm.
The three dimensional shoulder and fingertip positions were recorded at 240 Hz using a
Polhemus Liberty (Polhemus, Colchester, VT, USA) electromagnetic motion tracking
system. Six degrees of freedom Polhemus sensors were placed on the nails of the subject’s
right and left index fingertips, and on each shoulder (acromial process of the scapula).
Custom software was used to control the robot arm and record the movement data.
Procedures
Each PD patient was tested both On and Off STN DBS. The order of stimulation testing was
counterbalanced across patients. Patients were tested at least 1 h after turning the stimulator
off, or on, to ensure that the majority of the stimulator effects had expired for off-stimulation
testing, or returned for on-stimulation testing (Temperli et al., 2003).
There were two experimental conditions, one in which full visual feedback was provided
(‘vision’) and one in which the subject was blindfolded (‘no vision’). In order to avoid any
effect of experience with visual information of the target on proprioceptive localization, the
no vision condition always preceded the vision condition. Subjects were asked to extend
each index finger from a closed fist and place the ulnar side of each hand on their lap, 10 cm
from the respective knee joint. The initial hand positions were marked with a small square of
Velcro on each leg. Subjects returned their hands to the marked initial positions after each
trial.
The task followed the general procedures described in Tillery et al. (1994) for testing
proprioception during unconstrained two-hand apposition. The experimenter passively
moved the subject’s dominant hand to the target, and then returned to its initial position.
After a brief pause, the subject then reached with his/her non-dominant hand to “touch” the
remembered 3D target.
No vision condition—The subject’s eyes were covered using a black blindfold. The robot
arm moved to one of the five target locations in a pseudorandom order that was fixed across
subjects and vision conditions. The experimenter then passively moved the subject’s
dominant hand to touch the tip of the robot arm (the target) with the outstretched index
finger. Throughout the session, the experimenter reminded the subject to remain passive
during this time. After the subject’s index fingertip touched the tip of the robot, the
experimenter released the subject’s arm, subjects held the hand in contact with the robot for
approximately 1 s, and then the experimenter moved the subject’s passive arm back to the
initial position. During the return of the subject’s hand to the initial position, the robot arm
retracted to prevent contact with the robot during the subsequent localization movement
with the non-dominant arm. After a brief pause following the hand’s return to the initial
position, an auditory tone was given as a go signal, at which time subjects were to “touch”
the remembered target location with their non-dominant hand. Subjects were instructed to
make one smooth movement out, pause, and then return without corrections. They were also
instructed to reach at a comfortable speed. The experimenter supported the weight of the
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subject’s arm throughout the target presentation, except during the brief interval that the
subject’s hand was in contact with the target. The five targets were repeated eight times, for
a total of 40 trials.
Vision condition—Subjects had full vision and were allowed to look anywhere they liked
during the experiment. The same five target locations were presented in the same
pseudorandom sequence and repeated eight times for each target location. The procedures
and instructions were exactly same as the no vision condition.
Data processing
The movement data were processed using custom MATLAB (The MathWorks, Natick, MA,
USA) scripts. The time course of the hand tangential velocity was calculated by linearly
interpolating across the time and position data over 20 sample points around each time.
Hand movement onset and offset were initially identified as when tangential velocity fell
below 10% of its peak value for the first time before (for onset) or after (for offset) peak
tangential velocity. Every trial was visually inspected and movement onsets and offsets were
manually corrected if necessary. Trials that subjects initiated earlier than the go signal were
removed, as were trials in which there were recording anomalies, such as segments of
missing data. After removal of bad trials, at least five trials out of eight performed per target
location remained for each subject, although rarely was there ever more than one trial per
target missing. The overall trial rejection rate was a 1.7% (50/2880 total trials; five control
trials removed, 13 removed from DBS on, and 32 removed from DBS Off).
Data analysis and statistics
Pointing errors—Three primary error measures were used to analyze the data (B).
Denoting the medial–lateral direction as x, the inferior–superior direction as y, and the
anterior–posterior as z, the error measures were defined as follows:
3D error is the absolute distance in space between the specified target and the reach endpoint
for a given trial, providing an overall measure of performance. The formula is
where x, y, and z are the coordinates of the individual hand endpoints at every trial and tx, ty,
and tz are the coordinates of the given target. This measure was calculated for every subject,
trial, and vision/DBS/target condition without any explicit averaging for use in the linear
mixed models.
Constant error is the length of the vector from the target to the mean position of reach
endpoints to the target. The formula was
where ⟨x⟩, ⟨y⟩, and ⟨z⟩ are the individual hand endpoints averaged over all reaches to the
given target at tx, ty, and tz. This measure was calculated for every subject and vision/DBS/
target condition. Constant error in each spatial direction also was calculated by taking each
term under the square root separately. These component constant errors were defined as
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positive if the final finger position was to the right of the target, higher than the target, or
farther beyond the target with respect to the subject.
Variable error is the root mean square of the standard deviations of the endpoints along each
direction to each target, providing an overall measure of endpoint variability to a given
target. The formula is
where σx, σy, and σz are the standard deviations of the endpoints in each direction for each
target. This measure was calculated for every subject and vision/DBS/target condition for
use in the linear mixed models. Variable error in each direction was also considered
independently by taking the standard deviation in each direction separately.
These three error measurements are interrelated in the following ways (Berkinblit et al.,
1995; Adamovich et al., 1998, 2001; Poizner et al., 1998): if the constant error is
considerably larger than the variable error, the mean 3D error will have a similar value as
the constant error. If the constant error is small, that is, if the mean endpoint is near the
target, and the variable error is large, the mean 3D error will have a value closer to the
variable error.
In order to directly examine the effect of vision on performance, a no vision minus vision
score was computed for each error measure. The higher the positive value of this measure,
the greater the increase in error when vision was blocked.
Statistical analyses—To evaluate our first hypothesis of whether PD patients showed
proprioceptive deficits, analyses compared control subjects to STN DBS Off patients. To
evaluate whether STN DBS modulated proprioception, patients were compared On versus
Off STN DBS. Finally, to examine the effects of reduction in PD severity following STN
DBS therapy on the various pointing errors, the UPDRS score was added as a factor to the
linear mixed-model comparing patients On and Off STN DBS, described below.
Linear mixed-models, maximum likelihood method, were used to examine the effect of
group (e.g., control versus STN DBS Off), vision (no-vision versus vision), and target (up,
down, right, left, and back) on each dependent variable. Vision, target, and DBS (for PD
subjects) were identified as repeated effects. The random effects were first found on the full
data set by examining combinations of vision, target, and subject (Pinheiro and Bates, 2000)
and comparing their profiled deviance (Baayen et al., 2008). The random effect with the
lowest profiled deviance had a vectorized vision component by subject, and nesting of target
(vision∣subj/target in the lmer notation; Bates et al., 2012). Using 3D error as a sample-
dependent parameter the profiled deviance was greatly reduced (1672 less, χ2(4) = 1671.7, p
< 2.2e–16) over the scalar subject and target random effects. This random effect allows for
subject and subject by target variation on the effect of vision, and was used for all possible
cases. For analyses using single-vision components (i.e., no vision minus vision comparison)
or post hoc examination of just vision or no vision, there was not enough data for the
random effect to include the target interaction. Therefore, just the subject effect was
included (1∣subj in lmer notation).
Significance of the fixed effects was then tested by adding single terms and comparing to the
null model with one less level by the chi-square test on the profiled deviance (Baayen et al.,
2008). For example, to test for a dependence on vision, the comparison was to a model fit
with only an intercept term and one with the intercept plus vision. For interaction terms, if
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there were two main effects, A and B, then the model including all terms up to the
interaction (1 + A + B + A:B) was compared to that with only the single terms (1 + A + B)
and so on. All statistical analyses were done using R version 2.15.2 (R Core Team, 2012);
linear mixed models were fit using lme4 version 0.999902344-0 (Bates et al., 2012).
All distributions were examined for normality by inspection of the QQ plots and density
plots for each distribution. A number of distributions were skewed rather than normal (e.g.,
3D errors, constant errors, variable errors, and peak speed). When this occurred, the data
were log-transformed to reduce such skewing. A significance level of p < 0.05 was used.
RESULTS
PD subjects showed decreased peak speed
Fig. 2 presents peak speeds during reaches to each target location for each group. The speeds
were pooled over the no vision and vision conditions, since the same pattern of speeds over
targets held for all groups across vision conditions. STN DBS Off patients moved
significantly more slowly than control subjects (χ2(1) = 13.3, p < 0.001). Averaged over
targets, STN DBS Off patients’ peak speed was 95 ± 14 cm/s, which was 17% slower than
controls, who moved with a mean peak speed of 115 ± 13 cm/s. When STN DBS was
switched on, patients peak speed increased significantly (χ2(1) = 223, p < 0.001) to 104 ± 13
cm/s, a 9.5% increase. Over all groups there was a significant 10.7% increase in speed when
eyes were opened (χ2(1) = 11.8, p = 0.001). As expected, since the targets varied in required
movement amplitude, subjects’ speed was significantly different for the various targets
(χ2(4) = 76.6, p < 0.001). The fastest movement was to the upper most target (the farthest),
the slowest to the lowest target (the closest) and speeds were approximately the same across
the left, right, and back targets (Fig. 2). Thus, STN DBS Off patients showed slower speeds
than control subjects to all targets, reflecting the bradykinesia characteristic of PD. STN
DBS On patients showed intermediate speeds to control subjects and STN DBS Off patients,
reflecting the clinical benefit of the surgical therapy on this aspect of movement.
Endpoint distributions of PD patients and controls were qualitatively different
Fig. 3 presents endpoint distributions for a representative control subject (top row) and PD
patient with STN switched off (middle row) and on (bottom row). The left-hand panels show
a frontal view of the errors, and the right-hand panels a side view. Endpoints in the no vision
and vision conditions are shown within each view. The size of the targets in the figure has
been enlarged for clarity. Fig. 3 shows that the endpoints of the control subject in the no
vision condition were much closer to the targets than the PD patient, On or Off STN DBS.
The PD patient Off STN DBS showed a clustering of endpoints in the lower-central region
of space. Without vision, the patient reached beneath the upper target and above the lower
target, while making gross lateral errors to the rightmost target. The patient’s error
distributions improved with STN DBS, although not to the level of the control subject. Fig.
3 further shows that with vision, the endpoint errors were reduced for both of the subjects,
but markedly so for the PD patient.
Comparison of control subjects and patients Off STN DBS
Patients Off STN DBS showed increased errors—3D and constant errors. Fig. 4
presents the mean 3D error, constant error, and variable errors across targets for each group
in each vision condition. Fig. 4 shows that without vision, STN DBS Off patients had larger
3D and constant errors than control subjects for all targets except the left target. Pooled
across targets, control subjects had a mean 3D error of 8.7 ± 1.3 cm and a mean constant
error of 7.8 ± 1.2 cm, whereas, STN DBS Off patients had a mean 3D error of 12 ± 1.8 cm
and a mean constant error of 10 ± 1.6 cm (Table 2). Both STN DBS Off patients and control
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subjects showed a strong reduction of the errors with vision (χ2(1) = 51.3, p < 0.001). With
vision, STN DBS Off patients also had larger 3D (5.9 ± 1.0 cm) and constant errors (5.1 ±
1.0 cm) than control subjects (4.9 ± 0.77 cm 3D error and 4.2 ± 0.92 cm constant error).
Pooled across targets and vision conditions, STN DBS Off patients had significantly larger
3D (χ2(1) = 4.95, p < 0.03) and constant errors (χ2(1) = 4.18, p < 0.05) than control subjects.
The group × vision interaction was not significant for either 3D errors (χ2(1) = 1.2, ns) or
constant errors (χ2(1) = 0.44, ns).
In order to directly examine the effect of vision on performance, a no vision minus vision
score was computed for each error measure (see Methods). Fig. 5 presents the error change
without vision for each group pooled across targets. All error changes are positive, reflecting
larger errors without vision for each group. The greater the change in error, the greater the
improvement in performance due to providing vision. The improvement of 3D error with
vision for STN DBS Off patients was 61% (2.3 cm) greater than that for controls (χ2(1) =
3.96, p < 0.05). Thus, vision differentially improved the 3D errors of STN DBS Off patients
compared to control subjects. The improvement in constant errors with vision for STN DBS
patients was 36% (1.3 cm) greater than that of controls; however, this difference did not
reach significance.
Variable errors. Fig. 4C shows that, as with 3D and constant errors, STN DBS Off patients
had larger variable errors than control subjects across targets and vision conditions. Pooled
across targets, STN DBS Off patients had a mean variable error of 5.3 ± 0.55 cm without
vision, and 3.3 ± 0.35 cm with vision, whereas, those for control subjects were 4.1 ± 0.35
cm and 2.6 ± 0.22 cm, respectively (Table 2). Pooled across conditions, STN DBS Off
patients had significantly larger variable errors than controls (χ2(1) = 6.76, p < 0.01).
However, the Group × Vision interaction was not significant (χ2(1) = 0.01, ns). Fig. 5C
shows that there was a modestly larger increase in variable error without vision for STN
DBS Off patients than controls, although this difference was not significant. However, the
variable error in the medial–lateral direction did show significantly more improvement (0.7
± 0.3 cm) for STN DBS Off patients than controls (χ2(1) = 5.60, p < 0.02).
No vision–vision differences. We further isolated these dependencies by looking at the
vision and no vision conditions separately. For 3D error, STN DBS Off patients had a mean
3D error that was significantly larger (by 38%) than that of controls without vision (χ2(1) =
6.04, p < 0.02), but was not significantly larger with vision (χ2(1) = 3.68, ns). Similarly, the
mean constant error was significantly greater for STN DBS Off patients than for controls
without vision (by 28%) (χ2(1) = 4.15, p < 0.05), but not significantly different with vision.
On the other hand, the variable error was larger in PD subjects than of controls for both
vision conditions (χ2(1) > 4.44, p < 0.05). Thus, although variability in the medial–lateral
direction increased disproportionately in STN DBS Off patients compared to control
subjects when vision was blocked, the overall variable error was larger in STN DBS Off
patients than control subjects both with vision and without vision. Moreover, the 3D and
constant errors of STN DBS Off patients were similar to those of controls with vision, but
significantly larger without.
Comparison of patients On versus Off STN DBS
STN DBS selectively altered errors across conditions—3D and constant errors.
Fig. 4 shows that there was a robust effect of vision for patients On as well as Off STN
DBS. When patients were Off STN DBS (green lines1 in Fig. 4), their 3D errors dropped
from an average of 12 ± 1.8 cm without vision to 5.9 ± 1.0 cm with vision, and when they
1For interpretation of color in Fig. 4, the reader is referred to the web version of this article.
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were On STN DBS, 3D errors dropped from 11 ± 1.5 cm without vision to 6.2 ± 1.1 cm with
vision (Table 2). Similarly, constant errors dropped from 10 ± 1.6 to 5.1 ± 1.0 cm when
vision was provided for patients Off STN DBS, and from 9.1 ± 1.1 to 5.4 ± 1.2 cm when On
STN DBS. For 3D error, there was a significant Group × Vision (χ2(1) = 7.94, p < 0.006 and
Group × Target interaction (χ2(4) = 25.41, p < 0.001). Fig. 4A and Table 2 show that
providing vision reduced the 3D error more when patients were Off STN DBS than when
they were On (also see below), and that STN DBS acted selectively to decrease the 3D error
for the upper, right, and back targets. Constant error showed the same overall pattern (Fig.
4B), but there were no significant interactions with Group or a main effect of Group.
However, looking at the individual components of the constant error, there were significant
interactions of DBS and Vision (χ2(1) = 4.87, p < 0.03) and DBS and Target in the superior–
inferior direction (χ2(4) = 12.2, p < 0.02). For the DBS × Vision interaction, patients Off
STN DBS pointed farther beneath the targets than they did when On STN DBS when the
vision was blocked compared to when it was available. The DBS × Target interaction was
dominated by patients Off STN DBS reaching 2.3 ± 2.7 cm farther below the upper target
and 1.0 ± 2.0 cm farther above the lower target than when they were On STN DBS.
Variable errors. Surprisingly, switching DBS on increased variable errors without vision
(but not with vision) (Fig. 4C). Without vision, pooled across targets the variable error was
5.3 ± 0.55 cm when DBS was Off and 6.2 ± 0.73 cm when DBS was On, respectively.
However, with vision, the mean variable error dropped to 3.3 ± 0.35 cm and 3.2 ± 0.34 cm
for STN DBS Off and On, respectively. This interaction of DBS (on versus off) and Vision
(blocked versus free) for the variable error was significant (χ2(1) = 7.2, p < 0.002). There
also was a significant Group × Vision interaction for the component of the variable error in
the superior–inferior direction (χ2(1) = 6.19, p < 0.02). Patients On STN DBS had larger
variable superior–inferior errors without vision (χ2(1) = 4.28, p < 0.04), but not significant
with vision, than when they were Off STN DBS. Finally, there was a significant Group
effect for the anterior–posterior component of the variable error (χ2(1) = 4.06, p < 0.05).
STN DBS On patients had slightly larger variable errors in the anterior–posterior direction
than STN DBS Off (Table 2, χ2(1) = 4.06, p < 0.05), but this effect did not significantly
depend on vision. When directly examining the difference in variable error across the vision
conditions (Fig. 5C), unlike the case for 3D and constant error, blocking vision significantly
increased variable errors more (by 0.9 ± 0.9 cm) when patients were On STN DBS than
when they were Off (χ2(1) = 7.10, p < 0.01).
Taking the vision conditions separately, there was no significant difference in variable error
with vision when STN DBS was On versus Off. Without vision, variability increased by
15% (from 5.3 ± 0.55 to 6.2 ± 0.73 cm) when STN DBS was turned on (χ2(1) = 7.42, p <
0.01).
UPDRS scores predicted aspects of the spatial errors
To examine the dependence of the measured errors on the UPDRS score, we included the
UPDRS scores in linear mixed models as a factor that measured the slope of the dependence
of the error on the UPDRS. There were no UPDRS main effects or interactions for the 3D
error, constant error, or variable error (p > 0.054). This result indicates that changes in PD
severity did not significantly predict changes in 3D error, constant error, or variable error
when pooled over all conditions, or differentially do so within DBS and vision sub-
conditions. However, PD severity did predict changes in specific components of the constant
error. Within the separate spatial directions, there was a significant effect of UPDRS score
on constant error in the anterior–posterior direction (χ2(1) = 18.01, p < 0.001). This effect
indicated that with increasing PD severity, there was a modest anterior shift of endpoints (3
± 2 cm between the least and most severe patients). There also were significant interactions
between UPDRS scores and whether patients were On or Off STN DBS for the superior–
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inferior component of the constant error (χ2(1) = 11.9, p = 0.001), and the medial–lateral
constant error (χ2(1) = 10.74, p = 0.001). STN DBS reduced the effect of PD severity on
constant errors (medial–lateral: 0.21 ± 0.06 cm per UPDRS point less, superior–inferior:
0.16 ± 0.05 cm/point less). Finally, there was a significant UPDRS by target interaction
(χ2(4) = 20.4, p < 0.001). This interaction indicated that with increasing UPDRS scores (i.e.,
with increasing PD severity), patients tended to point farther below the upper target (by 2 ±
3 cm from the least to most severe patients), and farther above the lower target (by 6 ± 3 cm
from the least to most severe patients) (Fig. 6). This effect of PD severity on the superior–
inferior constant error component is interesting, since localizing the arm in 3D space
requires sensing and taking into account the effects of gravity on joint positions. However,
since there were no interactions of UPDRS score with visual feedback condition and DBS,
the degree of clinical improvement of patients with STN DBS switched on did not
differentially improve limb localization when vision was occluded.
DISCUSSION
In this study we examined 3D reaching movements to proprioceptively defined targets in PD
patients, and evaluated the effects of STN DBS on patients’ ability to localize these targets.
We used a task that previously has been shown to elicit proprioceptive coding of spatial
targets (Tillery et al., 1994). In this task, subjects must place the index finger of their non-
dominant hand in the remembered 3D location of the dominant hand. When visual feedback
is not provided, subjects are required to use exclusively proprioceptive cues in positioning
their finger in space. When visual feedback is provided, subjects may code the target in
visual coordinates, proprioceptive coordinates, or a combination of the two. If PD patients
show proprioception-specific deficits, they should show a relatively greater benefit from
receiving visual feedback of the limbs than would control subjects. Our first hypothesis was
that with STN DBS switched off, PD patients would show larger localization errors than
control subjects across conditions, and that providing vision would differentially improve
limb localization in the PD patients relative to control subjects. This hypothesis was for the
most part supported. We found that with STN DBS switched off, PD patients showed
significantly larger 3D, constant and variable errors than control subjects across conditions
(Fig. 4). Although providing visual feedback improved the performance of all subjects, it
improved 3D errors and one component of the variable error (in the medial–lateral direction)
for PD patients significantly more than for control subjects (Fig. 5A). Providing visual
feedback also improved constant and variable errors in PD patients Off STN DBS more than
for control subjects, but the magnitude of these improvements did not reach significance. 3D
error, however, provides an overall measure of performance, incorporating both constant
and variable errors (each of which trended toward differential improvement for PD patients
Off STN DBS relative to controls when vision was provided). Since, providing vision
significantly improved overall limb localization (3D error) in STN DBS patients more than
control subjects, our first hypothesis is supported. These data add to the growing body of
literature showing that PD patients have proprioceptive deficits, and do so across a wide
range of tasks.
Our second hypothesis was that switching STN DBS on would improve the ability of
patients to localize their limbs in space. This hypothesis was only partially supported. There
was no main effect of switching STN DBS on pooled across vision conditions for 3D or
constant errors. PD patients Off STN DBS had slightly larger 3D and constant errors than
when On STN DBS without vision, and slightly lower errors with vision (Fig. 4). However,
there was a significant interaction of STN DBS × Vision: switching STN DBS on improved
3D and constant errors more for patients reaching without vision than with vision (Fig. 5B).
However it did so at the cost of increased variable errors (Fig. 5C).
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PD patients show deficits in localizing the position of their limbs in 3D space based on
proprioceptive cues
With STN DBS switched off, PD patients showed significantly larger localization errors
across conditions than did control subjects, and providing visual feedback improved both 3D
errors and medial–lateral variable errors more for PD patients than control subjects. We
have previously found that PD patients off medication show increased variability
specifically in the medial–lateral direction when reaching to 3D targets without vision, and
that the origin of this variability was poor coordination of arm angles used to position the
limb in the medial–lateral direction (Poizner et al., 1998). Interestingly, when vision was
provided in the present study, the medial–lateral component of the variable error was
specifically found to improve more in PD patients Off STN DBS than in control subjects.
Both Poizner et al. (1998) and the present study used the same five spatial targets and the
same initial posture of the arm (upper arm vertical, forearm horizontal). The results suggest
that, at least under these experimental conditions, the lack of fidelity of the proprioceptive
signal in PD leads to increased uncertainty in positioning the arm in the medial–lateral
direction, and that this increased uncertainty may be due to the joint coordination
requirements of precisely positioning the arm in this direction.
Our results that PD patients Off STN DBS show proprioceptive deficits are consistent with
numerous studies demonstrating deficits in proprioception in PD patients (see Konczak et
al., 2009 for a review). In examining proprioception in PD patients, Demirci et al. (1997)
found that without vision of the hand, PD patients needed greater displacement of a finger to
perceive the same displacement as healthy individuals when the displacement was
referenced to a visual target. Consistent with the common observation that PD patients do
not perceive themselves as speaking softly, moving slowly, or making small movements
(Fox et al., 2012), Demirci et al. (1997) proposed that motor commands, corollary
discharges, and proprioceptive feedback are all reduced in PD. Indeed, behavioral training to
recalibrate PD patients’ proprioceptive perception of movement amplitude by providing
repeated comparisons of seen versus felt movement amplitudes leads to improved motor
performance (Fox et al., 2012). Our results fit nicely within such a framework.
PD limb-localization deficits are not due to motor or memory impairments
When subjects had full visual as well as proprioceptive feedback during target presentation
and response, they no longer were required to code targets in proprioceptive coordinates but
instead could use external visual coding, or a combination of visual and proprioceptive
coding. Thus, subjects could in large part bypass any proprioceptive processing deficits that
they might have. Since exactly the same set of targets and response requirements were used
in both conditions, the motor requirements of the task remained the same. Thus, the
impaired performance of the PD patients in the no-vision condition cannot be due to subjects
being impaired in moving to the various target locations, as errors were substantially
reduced for all subjects with visual feedback. Indeed, the 3D errors of the PD patients Off
STN DBS with visual feedback were on average 32% lower than those of the control
subjects without vision. Likewise, the same memory interval was used between target
presentation, retraction of the robot arm, and pointing response in the vision and no-vision
conditions. Again, since PD patients’ performance with vision was superior to that of
controls in the no-vision condition, the impaired performance of PD patients without vision
cannot be due to a memory impairment. Previous findings also demonstrate that PD patients
have no difficulty remembering the spatial locations of 3D targets in peripersonal space over
these brief intervals (Poizner et al., 1998; Adamovich et al., 2001). Rather, our findings
indicate that there is impaired proprioception in PD.
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STN DBS improves proprioceptive accuracy in limb localization, but reduces its precision
We found that the effects of STN DBS on proprioception were mixed. Switching STN DBS
on improved 3D and constant errors significantly more for patients reaching without vision
than with vision, although we did not find a major benefit of STN DBS on proprioceptive
accuracy. For 3D and constant errors, the DBS × Vision interaction depended upon target
(Fig. 4). There was substantial variation in accuracy across spatial targets for both groups
without vision. For PD patients Off STN DBS, the upper, right, and back targets showed the
largest increase in error over that of control subjects. These three targets elicit greater
intersegmental interactions than do the lower and left targets. Since proprioception is critical
for compensating for intersegmental interactions (Sainburg et al., 1993, 1995; Messier et al.,
2003), increased errors to these targets are consistent with PD patients having proprioceptive
deficits. Interestingly, PD patients and control subjects showed a much more uniform pattern
of accuracy across targets with vision. This differential pattern of errors across spatial
targets in the no vision and vision conditions is consistent with very different processes
underlying subjects’ localization of the limb in the two conditions, proprioceptive in the
former and visual in the latter.
Surprisingly, we found that STN DBS increased variable errors specifically when patients
reached without vision. We had hypothesized the opposite pattern would occur, since STN
DBS is thought to decrease pathological noise in affected basal ganglia–thalamo–cortical
circuits (Montgomery and Gale, 2008). Why STN DBS would increase a patient’s
uncertainty in limb localization is unclear. STN DBS has been reported to act as a “two-
edged sword,” in that its effects on motor performance interact with a patient’s residual
basal ganglia function, improving performance in patients with low baseline function and
impairing performance in patients with high baseline function (Chen et al., 2006; Joundi et
al., 2012). However, in the present study, in general we found that changes in patients’
motor severity with STN DBS did not interact with visual feedback in predicting accuracy
or precision in 3D limb localization. Whether baseline basal ganglia function or other factors
contributed to the increased variability in limb localization with STN DBS remains to be
determined.
Effects of DA therapy versus STN DBS on proprioception
As mentioned in the Introduction, the effects of dopaminergic therapy on proprioception
have been conflicting. Some studies find that it worsens proprioception (O’Suilleabhain,
2001; Wright et al., 2010), others that it has no effect (Maschke et al., 2003), and yet others
that it improves proprioception (Li et al., 2010). Since we tested 11 of the 12 patients while
they were on their dopaminergic therapy, we cannot completely rule out the possibility that
the medications contributed to the effects we found. However, patients receive markedly
reduced doses of anti-parkinsonian medications following STN DBS surgery, with
reductions typically being in the order of 50% (Benabid et al., 2009). Thus, it is unlikely that
the residual dopaminergic medications that the patients were on following surgery were a
determining factor in the findings.
Although, in general, there is a major overlap in the therapeutic benefits achieved by STN
DBS and dopaminergic therapy, the two therapies act through different mechanisms
(Montgomery and Gale, 2008), do not have congruent responses (Zaidel et al., 2010), and
differentially modulate Parkinson’s disease related brain networks (Mure et al., 2012; Ko et
al., 2013). Dopaminergic therapy is largely trophic and stimulates not only striatal activity,
but also widespread regions throughout the central nervous system where there are
dopamine receptors. DBS, in contrast, acts more locally, focuses on modulating the output
of the basal ganglia through its effect on the STN or on other brain regions activated
orthodromically, or especially antidromically from the STN (McIntyre et al., 2004; Li et al.,
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2007; Lalo et al., 2008; Gradinaru et al., 2009). Our data indicate that there is a beneficial
effect of STN DBS on the accuracy of multi-joint proprioception. Since the STN receives
direct afferents from primary and secondary somatosensory cortices (Canteras et al., 1988;
Juri et al., 2010) as well as from sensory processing areas of the thalamus (Lanciego et al.,
2004), STN DBS could stimulate these somatosensory-related areas antidromically and
interfere with their abnormal firing patterns, as well as those of cortical microcircuits of
which they are a part (Li et al., 2007). Thus, STN DBS could override pathological
synchronization within the cortico-basal ganglia sensorimotor loops improving limb
localization accuracy.
Models of the pathophysiology of PD and proprioception
The proprioceptive deficit in PD appears to be central rather than peripheral in origin, since
muscle spindle function and early cortical processing of proprioceptive information is
essentially unaffected (Dufresne et al., 1981; Seiss et al., 2003), but later cortical processing
is impaired (Seiss et al., 2003). Indeed, a substantial proportion of cells in the STN and
globus pallidus internal (GPi) of the monkey selectively respond to passive and active
movements, and are tightly tuned to movement in one direction (flexion or extension)
around a single joint, (DeLong et al., 1985; Filion et al., 1988). Recordings in PD patients
also reveal cells in the human STN and GPi respond to passive and active movement
(Rodriguez-Oroz et al., 2001; Abosch et al., 2002; Theodosopoulos et al., 2003). When
monkeys are made parkinsonian through MPTP treatment, the number of GPi cells
responding to passive or active movement increases, with most neurons now responding to
the movement of several joints rather than just a single joint (Filion et al., 1988). This loss in
neuronal response specificity to passive limb movement is also observed in the basal ganglia
receiving area of the thalamus (Pessiglione et al., 2005) and in the supplementary motor area
(Escola et al., 2002), a major cortical target of basal ganglia projections. Thus, in the
parkinsonian state, much noisier and less differentiated proprioceptive information is
propagated throughout the cortico-basal ganglia sensorimotor loop. This in turn may lead to
decreased accuracy in sensing limb position in the absence of vision in PD patients as
observed in the present experiment.
Classical models of the pathophysiology of PD have emphasized the anatomical segregation
of multiple looping structures linking frontal cortex and the basal ganglia, distinct pathways
within the basal ganglia, and excessive firing rates of basal ganglia output nuclei that lead to
excessive tonic inhibition of thalamus and cortex (Albin et al., 1989; Bergman et al., 1990).
However, it recently has become clear that temporal patterning within these looped
structures is of critical importance, and that the deficiency in dopamine in PD results in
excessive oscillations and pathological synchronization especially at beta band frequencies
(13–30 Hz) (Brown, 2003; DeLong and Wichmann, 2007; Weinberger and Dostrovsky,
2011). Such pathological beta oscillations have been recorded from the subthalamic nucleus,
globus pallidus and motor cortical areas in both primate models of PD and from PD patients
(Brown and Williams, 2005; Brown, 2007). Although the mechanisms of action of DBS are
not fully understood, high-frequency stimulation may override or “jam” pathological
oscillations (Rivlin-Etzion et al., 2008; Eusebio et al., 2012), thereby reducing faulty
information transmission and excessive noise in the circuit. This in turn could allow for
higher fidelity proprioceptive information transmission throughout the loop.
CONCLUSIONS
Although the motor deficits of PD patients are the most clinically apparent, patients show
sensory deficits as well. Proprioception is the key sensory requirement for multi-joint
coordination (Sainburg et al., 1993, 1995; Messier et al., 2003), and is important not only for
feedback correction but also for motor planning (Ghez and Sainburg, 1995). Thus,
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understanding deficits in proprioceptive processing in PD may help elucidate patients’
difficulties in motor behavior. Furthermore, STN DBS surgery for PD is being increasingly
utilized, but its effects on proprioception are virtually unexplored. Using a challenging
proprioceptive task, we found that PD patients OFF STN DBS showed substantial deficits in
multi-joint proprioception. Such deficits may in part underlie PD patients’ reliance on
external visual cues to guide their movements. We further found that STN DBS had mixed
effects on proprioception. Switching STN DBS on improved proprioceptive accuracy,
although it increased patients’ uncertainty about their limb positioning. The improvement in
the accuracy of 3D limb localization based on proprioceptive cues may be the result of high-
frequency stimulation overriding pathological oscillations in affected circuits, thereby
reducing faulty information transmission.
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Fig. 1.
(A) Schematic diagram of the subject’s position and the five target locations shown in
slightly rotated side view. Four targets (up, down, left, and right) formed a diamond (40-cm
diagonal length) in a frontal plane, centered in the subject’s midline. A back target (back)
was located 15 cm farther away from the first target plane along the subject’s midline. (B)
The three main error measures. 3D error is the absolute distance in space of the final finger
position from the target for each trial. Constant error is the distance of the mean of the
endpoints to the target, and variable error is the dispersion of the endpoints around the
endpoint mean location (see Methods).
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Fig. 2.
Peak tangential velocity of the hand during the reach averaged across vision conditions for
the five targets. Error lines combine standard errors of the mean within and across subjects.
The inset shows a frontal projection of the target space. Controls exhibit the fastest reaches,
PD patients Off STN DBS the slowest, and patients On STN DBS show intermediate
speeds. Thus, PD patients, as expected, show bradykinesia, which is significantly improved
with STN DBS.
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Fig. 3.
Endpoint distributions of a representative control subject (top row) and a PD patient when
STN DBS was switched off (middle row) and switched on (bottom row). Both front and side
views are shown. Within each view, the no vision condition is on the left (first and third
columns) and the vision condition is on the right (second and fourth columns). The large
(10-cm diameter) circles represent the five targets with unique colors, and filled dots are
individual trial endpoints with matching colors. Target size is enlarged for clarity. Scale bar
= 10 cm. Note the markedly increased localization errors of the PD patient, particularly
when vision was occluded and when STN DBS was switched off.
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Fig. 4.
3D error, constant error, and variable errors across targets. Filled circles (upper set, solid
lines) indicate no-vision, and open circles (lower set, dashed lines) indicate vision. All error
lines indicate standard errors combined within and across subjects. 3D error (A) and
constant error (B) show similar patterns. Without vision, control subjects had the smallest
errors, STN DBS On patients had intermediate errors, and STN DBS Off patients had the
largest errors. With vision, errors are markedly reduced for all groups. Controls subjects still
have the smallest errors, but the error difference between control subjects and STN DBS Off
patients is reduced from that of no vision. (C) Variable errors are smaller than constant
errors, and show a different pattern within the PD group. Without vision, control subjects
have the smallest variable errors, but unlike for 3D and constant errors, STN DBS Off
patients have intermediate errors while STN DBS On patients have the largest errors. With
vision, errors are reduced and similar across groups, although PD patients have slightly
higher errors than control subjects.
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Fig. 5.
Difference in error across the vision conditions (no vision minus vision). Increasing values
indicate increasingly larger errors in the no vision than vision condition, implying increased
difficulty in localizing the limb using proprioception. Whisker bars indicate 95% confidence
intervals across subjects. Asterisks indicate a significant difference between groups (p <
0.05). (A) 3D errors show disproportionately increased localization errors for STN DBS Off
patients than control subjects when vision is occluded; this deficit is partially reversed when
STN DBS is turned on. (B) Constant errors show the same pattern although the group
difference is significant only for STN DBS On versus Off. (C) Variable errors show a small
increase for STN DBS Off patients over that of control subjects, which is exacerbated by
switching DBS on.
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Fig. 6.
Constant error in the superior–inferior direction to each of the five targets separately for all
subjects with STN DBS On and Off. Positive values are upward. Error lines represent
standard errors over trials, the line is a least square fit within each target, and the shaded
region represents 95% confidence of the fit. Constant error in the superior–inferior direction
for the three targets at central height (left, back and right) show very little variability across
UPDRS. However, the upper target shows an increasing downward deflection and the lower
an increasing upward deflection with increasing UPDRS scores.
LEE et al. Page 24
Neuroscience. Author manuscript; available in PMC 2014 August 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
LEE et al. Page 25
Table 1
Clinical characteristics of PD patients
N Age Handedness Time post
surgery (years)
Disease
durationa
(years)
UPDRSb
(ON-DBS)
H & Yc stage
(ON-DBS)
UPDRS
(OFF-DBS)
H & Y stage
(OFF-DBS)
Medications
1 77 R 1.5 6 39 3 45 3.0 Lev, Sel,
Rop, Am
2 72 R 2.7 11 40 3 49 3 St, Rop, Par
3 79 R 4 8 28 2 44 2 Lev; St
4d 76 R 0.8 13 37 3 52 3 None
5 68 R 3 16 31 2 42 2 Lev; Pr; Ent
6 60 R 4 15 44 2 63 3 Lev; LevR;
Rop;Ent
7 68 R 2 14 34 3 42 3 Lev; St;
RopXL; Ras
8 60 R 1 10 41 3 48 3 Lev; Pr; Ras
9 61 R 1 10 28 3 39 3 St; Pr
10 76 R 3.7 10 37 3 51 3 Lev; Ras
11 61 R 3 7 32 3 50 3 Lev
12 58 R 3 10 37 3 54 3 St; Rop; Ras
LevR, Carbidopa/levodopa sustained release; Lev, Carbidopa/levodopa (regular formulation); Pr, Pramipexole; Sel, Selegiline; Ent, Entacapone;
Br, Bromocriptine; Rop, Ropinirole; St, Stalevo (Carbidopa/levodopa/entacapone); Ras, Rasagiline; Am, Amantadine; Rot, Rotigotine; Art, Artane
(trihexyphenidyl) and Par, Parcopa.
a
Duration is years since the first remembered parkinsonian symptom.
bUPDRS: United Parkinson’s Disease Rating Scale, Motor section (maximum score of 108). Higher scores indicate greater motor impairments.
c
H & Y stage: Hoehn and Yahr stage (maximum score of 5). Higher stages indicate more severe disease.
d
Tested off medications.
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Table 2
Mean ± standard errors across groups
Measure Vision Control DBS Off DBS On
3D error (cm) Blockked 8.7±1.3 12±1.8 11±1.5
Free 4.9±0.77 5.9±1.0 6.2±1.1
Constant error (cm) Blocked 7.8±1.2 10±1.6 9.1±1.1
Free 4.2±0.92 5.1±1.0 5.4±1.2
Variable error (cm) Blocked 4.1±0.35 5.3±0.55 6.2±0.73
Free 2.6±0.22 3.3±0.35 3.2±0.34
Peak speed (cm/s) Blocked 110±9.3 90±9.5 98±8.5
Free 120±8.4 100±9.9 110±9.6
Constant error x (cm) medial–lateral: + is to the right of the target Blocked −0.43±1.4 −1.2±2.4 −2.4±1.9
Free −0.5±0.54 −0.37±0.73 −0.52±0.74
Constant error y (cm) superior–inferior: + is above the target Blocked 3.3±1.4 2.4±1.8 3.4±1.8
Free 0.33±0.7 0.56±1.1 0.41±0.96
Constant error z (cm) anterior–posterior: + is beyond the target Blocked −1.3±1.6 −3.6±1.7 −2±1.9
Free −0.51±1.1 −0.27±1.3 +0.96±1.6
Variable error x (cm) Blocked 2.2±0.2 3.3±0.47 3.3±0.43
Free 0.91±0.095 1.3±0.19 1.2±0.15
Variable error y (cm) Blocked 2.5±0.32 3±0.36 3.4±0.4
Free 1.4±0.14 1.9±0.26 1.8±0.27
Variable error z (cm) Blocked 2.1±0.31 2.5±0.3 3.4±0.68
Free 1.8±0.22 2.1±0.24 2.1±0.28
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